Showing results (441-450 of 627) with videos related to
Sort By:
Pageof 63
Toxicology Letters|July 3, 2007
The DNA repair gene XPD/ERCC2 polymorphisms Arg156Arg (exon 6) and Lys751Gln (exon 23) are closely associatedJan Topinka, Irva Hertz-Picciotto, Miroslav Dostal, et al.The Clinical Investigator|May 1, 1994
Enormous hemangiosarcoma of the heartW Herr, A Schwarting, B Wittig, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2004
Surgical factors influence bladder cancer outcomes: a cooperative group reportHarry W Herr, James R Faulkner, H Barton Grossman, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|November 3, 2006
Inhalational exposure to carbonyl sulfide produces altered brainstem auditory and somatosensory-evoked potentials in Fischer 344N ratsDavid W Herr, Jaimie E Graff, Virginia C Moser, et al.Zeitschrift Fur Rheumatologie|March 1, 1996
Nodular nonsuppurative panniculitis in association with primary biliary cirrhosis and Hashimoto's thyroiditisW Herr, A W Lohse, T W Spahn, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1996
Specificities and functions of CD4+ HLA class II-restricted T cell clones against a human sarcoma: evidence for several recognized antigensM Heike, J Schlaak, H Schulze-Bergkamen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1984
Orchiectomy alone in the treatment of clinical stage I nonseminomatous germ cell tumor of the testisP C Sogani, W F Whitmore, H W Herr, et al.The Journal of Urology|May 18, 2013
Upper tract imaging surveillance is not effective in diagnosing upper tract recurrence in patients followed for nonmuscle invasive bladder cancerItay A Sternberg, Gal E Keren Paz, Ling Y Chen, et al.Cancer Research|November 15, 1987
Effects of intermittent diethylstilbestrol diphosphate administration on the R3327 rat prostatic carcinomaP Russo, G Liguori, W D Heston, et al.JAMA Oncology|February 15, 2024
Response to 2 Induction Courses of Bacillus Calmette-Guèrin Therapy Among Patients With High-Risk Non-Muscle-Invasive Bladder Cancer: 5-year Follow-Up of a Phase 2 Clinical TrialAndrew B Katims, Jacob Tallman, Emily Vertosick, et al.Pageof 63